Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(38%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_2
2
25%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(5)

Detailed Status

Completed5
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (25.0%)
N/A6 (75.0%)

Trials by Status

completed563%
recruiting338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8